Supernus Pharmaceuticals (SUPN) EBT Margin (2011 - 2025)
Supernus Pharmaceuticals' (SUPN) quarterly EBT Margin came in at 0.9% in Q4 2025, down 1605.0% year-on-year from 0.06% in Q4 2024, and up 97.0% on a QoQ basis from 30.17% in Q3 2025.
Supernus Pharmaceuticals (SUPN) EBT Margin (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 15 years of EBT Margin data on file, last reported at 0.9% in Q4 2025.
- On a quarterly basis, EBT Margin fell 1605.0% year-over-year to 0.9% in Q4 2025; TTM through Dec 2025 was 6.82%, a 2161.0% decrease from a year earlier, with the FY2025 full-year figure at 6.82%, down 2161.0% from the prior year.
- EBT Margin for Q4 2025 stood at 0.9%, up from 30.17% in the prior quarter.
- Over the last five years, EBT Margin for SUPN reached as high as 25.58% in Q3 2024 and fell as low as 30.17% in Q3 2025.
- Historically, EBT Margin has averaged 6.01% across 5 years, with a median of 6.54% in 2023.
- Across the five-year window, EBT Margin surged 2826 bps in 2024 and sank 5575 bps in 2025, its largest moves.
- Year by year, EBT Margin stood at 1.29% in 2021, then soared by 1529 bps to 21.0% in 2022, then plunged by 97 bps to 0.6% in 2023, then surged by 2414 bps to 15.15% in 2024, then sank by 106 bps to 0.9% in 2025.
- Per Business Quant data, the three most recent EBT Margin figures were 0.9% in Q4 2025, 30.17% in Q3 2025, and 10.07% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.90% |
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | 10.07% |
| Mar 31, 2025 | -3.89% |
| Dec 31, 2024 | 15.15% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 15.63% |
| Mar 31, 2024 | 0.17% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | 6.43% |
| Jun 30, 2023 | -12.63% |
| Mar 31, 2023 | 5.86% |
| Dec 31, 2022 | 21.00% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | 6.66% |
| Mar 31, 2022 | 9.65% |
| Dec 31, 2021 | 1.29% |
| Sep 30, 2021 | 19.51% |
| Jun 30, 2021 | 22.10% |
| Mar 31, 2021 | 8.35% |